The promising future of breast reconstruction market
![]() |
Breast Reconstruction market |
The
Breast Reconstruction Market is estimated to be valued at US$ 567 million in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period
2023-2030, as highlighted in a new report published by Coherent Market
Insights.
Market Overview:
Breast reconstruction involves surgical procedures that recreate a breast shape
from tissues and implants, providing improved aesthetics and boosting
confidence of patients who have undergone mastectomy. Implant-based and
autologous flap reconstruction are commonly adopted techniques in breast
reconstruction procedures.
Market Dynamics:
Increasing breast cancer incidence rates and growing awareness about breast
reconstruction options available post mastectomy are major factors responsible
for the projected growth of the breast reconstruction market over the forecast
period. According to the American Cancer Society, breast cancer incidence rates
increased by 0.5% annually from 2013 to 2018. Furthermore, technological
advancements in breast reconstruction procedures and implants are also expected
to support the market growth. Newer procedures involving 3D printed implants
capable of better matching natural breast tissue are being developed by leading
manufacturers.
Market key trends:
The breast reconstruction market has been witnessing a rise in the number of
procedures carried out using tissue expanders. Tissue expanders help create
space under the skin and muscles of the chest for an implant or the patient's
own tissue to be placed. This trend can be attributed to the growing preference
for tissue expansion as it provides a more natural shape and feel compared to
other alternatives. Furthermore, technological advancements in tissue expanders
such as the availability of round and adjustable designs have boosted their
adoption among patients and surgeons.
SWOT Analysis
Strengths: Availability of various reconstruction procedure options such as
implant, autologous reconstruction using DIEP or TRAM flap technique suits
patient needs.
Weaknesses: High cost associated with autologous reconstruction procedures
limits their access. Post-surgery complications associated with implants
requires revision surgeries.
Opportunities: Rising breast cancer incidence rates worldwide presents growth
prospects. Increasing reimbursement and favourable regulations in developed
nations support market growth.
Threats: Strong competition from alternative treatments and lack of
reimbursement in developing nations are key challenges.
Key Takeaways
The Global
Breast Reconstruction Market Size was valued at US$ 567 million in 2023 and is expected to reach US$ 794 million by 2030, expanding at a
CAGR of 2.7% from 2023 to 2030.
Rapid growth can be attributed to rising cancer incidence rates globally. The
APAC region dominates the market currently due to high cancer burden in China
and India. North America is expected to witness lucrative growth owing to advanced
medical care and presence of major players in the US.
Regional analysis
The Asia Pacific region currently dominates the global market backed by the
rising cancer prevalence in highly populated countries such as China and India.
According to International Agency for Research on Cancer, China accounted for
over 25% of the global breast cancer cases in 2020. Additionally, improving
access to healthcare infrastructures in developing Asian countries is
supporting the uptake of breast reconstruction procedures in the region.
Key players operating in the breast reconstruction market are Polytech Health
& Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson),
Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra
LifeSciences, and Wanhe. The major players are focusing on new product
launches, geographic expansions and mergers and acquisitions to get a larger
share of the market.
Read More - https://www.insightprobing.com/breast-reconstruction-market-trends-analysis-share-demand-and-size-forecast/
Comments
Post a Comment